CDXC

ChromaDex Corporation

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

CDXC price

ChromaDex

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CDXC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CDXC

Valuation

P/E

0.00

Sector -0.16

Industry 2.77

P/BV

0.00

Sector 1.93

Industry 2.37

P/Revenue (PSR)

Sector 1.67

Industry 1.97

EV/EBITDA

-5.96

Sector -55.30

Industry -73.25

EV/EBIT

-6.26

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

Sector 0.91

Industry 1.07

P/Net Current Assets

0.00

Sector -24.70

Industry -5.25

P/Working Capital

0.00

Sector -5.32

Industry 3.11

EPS

0.11

Sector -0.79

Industry -0.61

BVPS

0.60

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

61.84%

Sector 48.28%

Industry 50.49%

EBITDA Margin

25.65%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

24.42%

Sector -62.93%

Industry -21.31%

Operating Margin

7.75%

Sector -23.12%

Industry -27.36%

Net Profit Margins

8.59%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.43

Sector 0.13

Industry 0.15

Profitability

ROE

18.55%

Sector -31.93%

Industry -27.86%

ROA

12.52%

Sector -28.25%

Industry -27.56%

ROIC

358.81%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.57

Sector 1.85

Industry 1.98

Net Debt / EBITDA

-5.96

Sector -42.46

Industry -72.45

Net Debt / EBIT

-6.26

Sector -37.26

Industry -7.11

Net Debt / Equity

-0.97

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.00

Sector -0.72

Industry 0.10

Equity/Assets

0.68

Sector 0.43

Industry 0.45

Liabilities/Assets

0.32

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

25.15%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF ChromaDex ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$1.22

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CDXC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CDXC ChromaDex Corporation	$0.00	-	0.00%	0.00	0.00	18.55%	8.59%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.88	2.88	7.61%	15.95%
WAT Waters Corporation	$413.55	38.94%	0.00%	244.98	2.68	1.09%	3.58%
IQV IQVIA Holdings Inc.	$261.90	38.72%	0.00%	31.33	6.86	21.89%	8.12%
SHC Sotera Health Company	$19.32	17.09%	0.00%	33.54	8.24	24.56%	13.44%
CGEN Compugen Ltd.	$2.62	77.89%	0.00%	6.99	2.77	39.65%	47.54%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CDXC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ChromaDex

ChromaDex Corporation

Average Investor10 user rating

4.0 (1 people)

United States

26 years

Founded: 2000

2008

Time since IPO - 18 years

110

Employees

ChromaDex Corporation (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $46.09 million.

The company employs approximately 110 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, ChromaDex Corporation reported $99.59 million in revenue, generating net income of $8.55 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CDXC.

Market cap

Net worth

$46.09 million

$46,090,000.00

Assets

$68.28 million

$68,280,000.00

Total Shares Outstanding

77.00 million

77,000,000

Average Daily Trading Volume

$872.97 Thousand

$872,974.22

Sector

Health

Industry

Life Science Tools and Services

CDXC

CDXC revenue and profits

Financial Results CDXC

DRAG THE FRAME TO SEE MORE DATA

CDXC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75